having alpha [RSABE / ABEL]

posted by martin  – Austria, 2013-03-28 14:08 (2968 d 04:46 ago) – Posting: # 10304
Views: 17,944

Hi Helmut & simulants !

What do you think about a kind of adaptive group-sequential design with one interim analysis (i.e. estimate CV) allowing to make a decision regarding average BE or scaled BE in the final analysis? This may solve the problem.

best regards

martin

Complete thread:

Activity
 Admin contact
21,460 posts in 4,486 threads, 1,511 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Thursday 18:54 UTC (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5